Investors Should Take Note Of Akebia Therapeutics Inc (AKBA)
Akebia Therapeutics Inc (AKBA) concluded trading on Wednesday at a closing price of $3.99, with 4.7 million shares of worth about $18.74 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 107.81% during that period and on July 09, 2025 the price saw a […]
Is Akebia Therapeutics Inc (NASDAQ: AKBA) Proving The Doubters Wrong?
Akebia Therapeutics Inc (AKBA) concluded trading on Wednesday at a closing price of $3.63, with 4.62 million shares of worth about $16.76 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 86.15% during that period and on July 02, 2025 the price saw a […]
Akebia Therapeutics Inc (AKBA) Volatility Spurs A Quest For Clarity
Currently, there are 261.64M common shares owned by the public and among those 251.87M shares have been available to trade. The company’s stock has a 5-day price change of 14.62% and 103.11% over the past three months. AKBA shares are trading 106.32% year to date (YTD), with the 12-month market performance up to 266.36% higher. […]
Look At Analyst Expectations For A Better Read On Akebia Therapeutics Inc (NASDAQ: AKBA)
Currently, there are 261.64M common shares owned by the public and among those 251.86M shares have been available to trade. The company’s stock has a 5-day price change of 13.64% and 80.56% over the past three months. AKBA shares are trading 71.05% year to date (YTD), with the 12-month market performance up to 215.53% higher. […]
Akebia Therapeutics Inc (NASDAQ: AKBA) Stock In Prove Me State
Akebia Therapeutics Inc (AKBA) concluded trading on Thursday at a closing price of $3.01, with 7.55 million shares of worth about $22.71 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 60.11% during that period and on May 29, 2025 the price saw a […]
Akebia Therapeutics Inc (NASDAQ: AKBA) – Suitable For Long Term Buy?
Currently, there are 261.64M common shares owned by the public and among those 251.86M shares have been available to trade. The company’s stock has a 5-day price change of 15.23% and 35.27% over the past three months. AKBA shares are trading 47.37% year to date (YTD), with the 12-month market performance up to 137.29% higher. […]
Akebia Therapeutics Inc. (NASDAQ: AKBA): To Buy Or Not To Buy, That Is The Question
Akebia Therapeutics Inc. (AKBA) concluded trading on Thursday at a closing price of $1.47, with 3.54 million shares of worth about $5.21 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 16.67% during that period and on Thursday the price saw a loss of […]